初次全膝關(guān)節(jié)置換術(shù)圍手術(shù)期應(yīng)用利伐沙班與阿哌沙班抗凝治療的研究
[Abstract]:Objective to evaluate the efficacy and complications of low molecular weight heparin calcium (LMWH), rivastabine and piperazabine in the perioperative treatment of primary total knee arthroplasty. Methods from April to September, 2014, 60 patients with osteoarthritis of knee joint underwent the first total knee arthroplasty. They were randomly divided into three groups: low molecular weight heparin calcium group, rivastaban group and piperzapan group, 20 cases in each group. The recessive blood loss was calculated according to the specific volume of erythrocyte in perioperative period, and the changes of blood routine and limb circumference of suprapatellar 10cm and subpatellar 10cm were monitored before and 1 day after operation. The effects of three groups of drugs on recessive hemorrhage, massive hemorrhage, non-severe hemorrhage, blood transfusion demand, changes of coagulation function, changes of liver and kidney function, postoperative wound infection, deep vein thrombosis and pulmonary embolism were analyzed in three groups. Results the occult blood loss in the three groups was 937.4 鹵308.7 ml, 887.8 鹵311.4 ml, 889.8 鹵296.9 ml, respectively (P 0.05). The recessive blood loss was correlated with the changes of peripatellar diameter of the upper patellar and subpatellar limbs in the three groups with statistical significance (P0.05). There was significant difference in peripatellar diameter between the three groups (P 0.05). There was no significant difference in the incidence of complications such as deep venous thrombosis and pulmonary embolism among the three groups (P 0.05). Conclusion low molecular weight heparin calcium, rivastabine and piperazabine can effectively prevent the occurrence of VTE in patients undergoing primary total knee arthroplasty, and there is no significant difference in postoperative complications. Its effectiveness and safety are equal. Low molecular weight heparin calcium (LMWH), compared with rivasaban, increased the swelling of the lower extremity of the operative side.
【學(xué)位授予單位】:寧夏醫(yī)科大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2015
【分類號】:R687.4
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 湯雄鷹,魏素芳;老年患者全膝關(guān)節(jié)置換術(shù)感染的預(yù)防[J];中華醫(yī)院感染學(xué)雜志;2004年06期
2 李秋月,周英,應(yīng)秀華;全膝關(guān)節(jié)置換術(shù)伸膝功能康復(fù)的三階段護(hù)理10例[J];中國實(shí)用護(hù)理雜志;2004年16期
3 尹繼紅;;全膝關(guān)節(jié)置換術(shù)156例康復(fù)指導(dǎo)[J];齊魯護(hù)理雜志;2008年04期
4 鄭瓊;;單側(cè)全膝關(guān)節(jié)置換術(shù)護(hù)理體會[J];實(shí)用中醫(yī)藥雜志;2009年03期
5 張艷娟;蘇莉;;同期雙側(cè)全膝關(guān)節(jié)置換術(shù)的護(hù)理體會[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2009年10期
6 韓紅云;;健康教育在全膝關(guān)節(jié)置換術(shù)中的應(yīng)用[J];內(nèi)蒙古中醫(yī)藥;2010年24期
7 申作柱;;全膝關(guān)節(jié)置換術(shù)治療重度膝關(guān)節(jié)骨性關(guān)節(jié)炎的臨床療效分析[J];中國醫(yī)藥指南;2013年14期
8 毛冬竹,黃玉環(huán);全膝關(guān)節(jié)置換術(shù)的護(hù)理[J];黑龍江醫(yī)學(xué);1999年08期
9 畢擎,夏冰,張帆,鐘永偉;全膝關(guān)節(jié)置換術(shù)11例臨床分析[J];浙江醫(yī)學(xué);2001年01期
10 陳佩珠;全膝關(guān)節(jié)置換術(shù)的護(hù)理[J];安徽中醫(yī)臨床雜志;2003年04期
相關(guān)會議論文 前10條
1 周謀望;叢曉東;;全膝關(guān)節(jié)置換術(shù)后早期康復(fù)[A];2002年第9屆全國運(yùn)動醫(yī)學(xué)學(xué)術(shù)會議論文摘要匯編[C];2002年
2 金思東;諸葛天瑜;王西迅;李恩典;吳曉君;孫捷;何建軍;袁浩;;全膝關(guān)節(jié)置換術(shù)治療膝關(guān)節(jié)骨性關(guān)節(jié)炎[A];浙江省中西醫(yī)結(jié)合學(xué)會骨傷科專業(yè)委員會第十一次學(xué)術(shù)年會暨省級繼續(xù)教育學(xué)習(xí)班論文匯編[C];2005年
3 金思東;諸葛天瑜;王西迅;李恩典;吳曉君;孫捷;何建軍;袁浩;;全膝關(guān)節(jié)置換術(shù)治療膝關(guān)節(jié)骨性關(guān)節(jié)炎[A];浙江省中西醫(yī)結(jié)合學(xué)會骨傷科專業(yè)委員會第十一次學(xué)術(shù)年會暨省級繼續(xù)教育學(xué)習(xí)班論文匯編[C];2005年
4 龔蕉椒;陳瀾;楊穎;楊s,
本文編號:2133484
本文鏈接:http://sikaile.net/yixuelunwen/waikelunwen/2133484.html